Beatriz Gros @Bealoquebea Twitter profile

Pinned Tweet

Beatriz Gros

5 months

🌟Ever found yourself doubting about IBD new drugs doses? or forgetting Thiopurine metabolism details? I've been there too So I thought it could help having "IBD Cheat Sheets" and that is what I did: I hope it helps as much as it helps me 1/2 #IBD

30

121

329

Last Seen Profiles

@_Likybo

@GCGA

@hijabjilbab1

@ArizonaGymCats

@hijabjilbab1

@jandakembangstw

@Pecintastw4050

@stw_pdg

@RacingManiacos

@nspiuzzi

@CapNgan

@SayeedBernard

@stw46

@Myllmo

@chaewons1stfan

@Golf_Saudi

@maloneathletics

@euskalhintxak80

@BinorRaja

@denver_gigi

@crazyogurtz

@SometimesItsWr1

@ichikahikari_

@_Ashdown

@flo_wershower

@YourFavOck

@stw46

@billingham229b

@iamiggyola

@prajwalmanipal

@___axfw

@oneilandrews

@LetsGo_Ugo

@GiselaMare97231

@lysmarieetv

@La_Maritrini

Beatriz Gros

@Bealoquebea

1 year

Many of you know I love timelines & I have been updating the one on IBD trials/studies for some time🧵 The landscape is changing fast & there isnt enough space here to share all the content As such I have created a website to collect it all and to make it interactive

50

160

449

Beatriz Gros

@Bealoquebea

1 year

Has it ever been difficult for you to find the latest guidelines or consensus on IBD from different societies? Not anymore ⭐️New section “guidelines” in And tomorrow newsletter with a new evidence corner and new trials added 🤩

26

120

339

Beatriz Gros

@Bealoquebea

2 years

After my previous summary of IBD studies,I finished yesterday this timeline which is more visual. I hope it can be useful to see where we come from and where we go. There may be some mistakes,but please I did it with my best intention, same with missing studies.

36

76

323

Beatriz Gros

@Bealoquebea

1 year

IBD classifications,scores and indices are something we often use and I thought having the most used ones all together could be helpful ⭐️New section Suggestions are welcome 🙏🏻

7

98

283

Beatriz Gros

@Bealoquebea

17 days

My website made it to the US 🤩 This is like a dream although I have to admit my biggest followers come from 🇺🇸 with >45K visits within 15 months @DDWMeeting #DDW2024

26

39

270

Beatriz Gros

@Bealoquebea

2 years

I don’t share much of my personal life on twitter but this day was absolutely worth it. @fjseruf and I finally married. Living in 2 different countries for 18 months has not stopped us!!

76

7

269

Beatriz Gros

@Bealoquebea

1 month

Someone reached out suggesting I compile a summary of #IBD H2H trials His suggestion motivated me to complete the one I had 🌟So, here it is over 35 trials. Hope it proves helpful! You'll have to access the website to view it in full. Happy to add

19

75

234

Beatriz Gros

@Bealoquebea

9 months

⭐️Exciting news! Our ulcerative colitis review published in @JAMANetwork @JAMA_current A massive shoutout to the brilliant @gilkaplan and fantastic support from @lasser_karen This project has been a work of passion& meaningful networking #UC 1/2

Ulcerative Colitis in Adults—A Review

This review discusses the epidemiology, pathophysiology, diagnosis, and treatment of ulcerative colitis in adults.

jamanetwork.com

19

59

218

Beatriz Gros

@Bealoquebea

3 months

Years ago, I shared the first #IBD timeline here w the names of relevant studies With the advent of the web, updates of those slides paused ⭐️at #ECCO2024 I noticed it could still be useful. I did an updated version (incl 2024!) Hope it helps! Happy to add/change anything

11

49

218

Beatriz Gros

@Bealoquebea

6 months

🌟 November-Exciting News IBD-EII! 🌟 🧵 🆕 Introducing the new "IBD multifactorial" section at Delve into the risk & protective factors that have been associated with IBD onset. Over 190 studies organized per year and type of factor!

11

78

207

Beatriz Gros

@Bealoquebea

6 months

1/ In my 'Back to basics' in #IBD , today I delve into the tumor necrosis factor #TNF history 🧵Let's talk about TNF-alfa, one of the most well-known cytokines in IBD from discovery to present-day applications It's discovery is fascinating

6

62

192

Beatriz Gros

@Bealoquebea

2 months

JAK-STAT pathways can be complex to understand, gaining insight into their functions helps us comprehend the consequences of their blockade. Bearing this in mind, I have done a summary attempting to synthesize this complexity focusing on #IBD therapies, I hope it proves useful.

11

45

189

Beatriz Gros

@Bealoquebea

1 year

I have been working on this project for months. A website constantly being updated with summaries of all the important studies in IBD. At the moment over 140 studies.

13

54

184

Beatriz Gros

@Bealoquebea

5 months

1/ I've read the TACOS trial on the use of tofacitinib in acute severe #UC I'll break down some important highlights &/or reflections which I found of interest (In any case, I recommend reading the full study) 🔎Important tweets are number 7 & 8

7

47

175

Beatriz Gros

@Bealoquebea

2 years

When Attending to congresses I recommend keeping this in mind & being extremely polite and grateful to the person who has presented. The effort of preparing the talk plus the pressure of talking in front of others should be taken into account. #UEGWeek #UEGWeek22 @my_ueg

6

45

162

Beatriz Gros

@Bealoquebea

1 year

Multiple successive switches from IFX originator to biosimilars are effective and safe in patients with IBD, irrespective of the number of IFX switches. 🧵 Our paper is open for you to read.

7

40

156

Beatriz Gros

@Bealoquebea

4 months

Celebrating one year since I launched In a year I collected >950 studies with >220k visits & >20k downloads Huge thanks to everyone who supported along the way! 🙌 “In a gentle way, you can always shake the world”

Beatriz Gros

@Bealoquebea

1 year

Many of you know I love timelines & I have been updating the one on IBD trials/studies for some time🧵 The landscape is changing fast & there isnt enough space here to share all the content As such I have created a website to collect it all and to make it interactive

50

160

449

23

20

159

Beatriz Gros

@Bealoquebea

5 months

As many are sharing their top 2023 articles, remember on you'll find the most important RCTs & many other 2023 relevant studies This has been an exciting adventure that I never thought would go this far in less than a year Thanks for all the support

9

34

154

Beatriz Gros

@Bealoquebea

7 months

In my 'back to basics' in #IBD , I delve into the world of biomarkers 🧵Let's talk about the interesting C-reactive protein #CRP 📖 Discovery dates back to 1930 by Tillett & Francis (Rockefeller institute for Medical Research 🇺🇸) ⬇️

3

46

152

Beatriz Gros

@Bealoquebea

3 years

I summarize many concepts for my residents and myself. I did one of important studies in IBD ordered by year.Some suggested that I share it,as it may be useful to other people. There may be some mistakes but,did it with my best intention.I know some info is left but cannot extend

17

39

148

Beatriz Gros

@Bealoquebea

11 months

For those who inquired about its authorship, these are the IBD timeline graphs I created! Feel free to use it if it benefits you! 📎Attached are both the complete version in a single slide and the separated version for your convenience. #IBD #MedEd

9

34

139

Beatriz Gros

@Bealoquebea

4 months

I grew up surrounded by science; my mum was a researcher throughout her life & dedicated herself entirely to it In her memory & in honor of all women striving to carve out a place in a world that isn't always fair & equal for them 📷:mum giving me my MD title #WomenInScience

16

6

135

Beatriz Gros

@Bealoquebea

1 year

Ileocaecal resection in newly diagnosed CD associated to improved long-term outcomes compared to TNFinh very nice presentation @ManasiAgrawalMD #IBD #ecco2023 More data supporting the LIR!C trial

3

42

135

Beatriz Gros

@Bealoquebea

3 months

At this #ECCO2024 , I'm presenting my first poster from ⭐️This project became a reality thanks to everyone who supported it Despite navigating the challenges w limited experience on websites,my passion propels this endeavor &I'm eager to share it with you

12

29

135

Beatriz Gros

@Bealoquebea

4 months

Is there anything that I may have missed from the pre biologic/small molecule/immunesupressant screening? It has been something that some of you asked me to add to Please feel free to improve this summary, I really appreciate your help

25

35

131

Beatriz Gros

@Bealoquebea

1 year

I’m still processing that I will be presenting at #DDWMeeting @AmerGastroAssn Big thanks to @charlie_lees & @LauranneDerikx for your amazing support&mentoring over this almost 2 wouldnt have been possible without you.Also to rest of authors🙏🏻 #hereforDDW

17

8

124

Beatriz Gros

@Bealoquebea

18 days

Positioning #IBD therapies greatly presented by @IBDMD at #DDW2024 @DDWMeeting

2

32

120

Beatriz Gros

@Bealoquebea

6 months

Still, I am at a loss for words to describe how difficult It feels to leave Thanks to everyone at WGH, you are really incredible Charlie, thanks for trusting in my abilities & reminding me of all that I am capable of doing I will always be indebted.Our friendship means a lot 🙏🏻

Charlie Lees

@charlie_lees

6 months

After 2.5 years, today is Bea's last official day working in the Edinburgh IBD Unit. It is difficult to express here what an incredible impact she has made on the entire team in Edinburgh. Her hard work, dedication, passion and joy for the every day has impacted us all and

10

11

209

5

6

117

Beatriz Gros

@Bealoquebea

4 months

Data from PROFILE trial Amazing presentation by Nuru Noor Top down IFX+IMM from diagnosis of #CD shows: -⬆️sustained steroid & surgery-free remission -No increase in serious infections -67% endoscopic remission rate and 10x ⬇️in urgent abdominal surgery #ECCO2024 #ECCO24

3

36

116

Beatriz Gros

@Bealoquebea

4 months

Coconut water in mild-mod UC vs placebo (both arms+standard therapy) 🌟 response 57.1% vs 28.3%, p=0.014 🌟 remission 53.1% vs 28.3%, p=0.02 FC & 🦠 changes but not endoscopy w8 @ShomronH & @RichardPollok will enjoy this reading, 🤔 outside 📦 .

6

28

111

Beatriz Gros

@Bealoquebea

10 months

🎉 Exciting news! My website has hit an incredible milestone over- 100,000 visits in just 6 months! ✨It's a testament to the power of passion and determination. 💪 #ChaseYourDreams #PassionProjects #IBD

14

11

111

Beatriz Gros

@Bealoquebea

2 years

Thank you very much @Iagorlago and @Iris_Dotan for this prize. I feel so grateful, this would have never been possible without @charlie_lees @LauranneDerikx @PlevrisN @IBDNathan @Gastro_GRJ

22

7

110

Beatriz Gros

@Bealoquebea

3 years

🇪🇸🇬🇧Voy a escribir una línea de tuits para explicar por si le sirve a alguien cómo proceder para trabajar de médico en UK contando con los cambios del Brexit. Lo cuento según lo que he tenido que hacer,puede que haya más opciones. Si alguien necesita ayuda no dude en contactarme.

19

25

109

Beatriz Gros

@Bealoquebea

2 months

The impact of the adherence to Mediterranean diet and physical activity on #IBD prognosis ⭐️Healthy lifestyle was associated with: - Lower risk of mod-severe relapses (aHR, 0.250; 0.093-0.670) - Steroids use (aHR 0.292; 0.103-0.828) - Lower risk of mod-severe relapses (aHR

1

35

108

Beatriz Gros

@Bealoquebea

3 months

My younger sister Monica Gros defended her thesis today, the result of great effort and passion ☀️She works as a mountain rescue doctor, and yet she managed to complete her doctoral thesis in her spare time for free (like almost all doctors in Spain) on IBS and the intestinal

10

3

107

Beatriz Gros

@Bealoquebea

8 months

Excited to unveil the latest additions! Check out the updated timeline Feel free to use it if it helps you 😊 Explore this and much more in #IBD #MedEd

2

24

100

Beatriz Gros

@Bealoquebea

3 months

A number of relevant changes have been made to the new #CD ECCO guideline to be published in JCC ✅new drugs ✅language change no “conventional” therapy but “evidence based” ✅downgrading some old therapy ✅role of EEN And much more! Cannot wait to read it 🤩 Great job @IBD_MB

4

27

100

Beatriz Gros

@Bealoquebea

19 days

Adherence to mediterranean diet in newly diagnosed #CD was associated with ⬇️ levels of primary bile acids ⬇️microbial disbiosis ✅ non-complicated CD course #DDW2024 @LGodny congrats

4

29

99

Beatriz Gros

@Bealoquebea

4 months

The rational of advanced combination therapy in #IBD @bruce_sands1 presenting a great overview of the past and future of these combinations at #ECCO2024 #ECCO24

1

23

99

Beatriz Gros

@Bealoquebea

1 year

Ileocaecal surgery for new CD is associated with improved long-term outcomes compared to AntiTNF nicely presented by @ManasiAgrawalMD at #DDW2023 #AGALIVE #IBD

4

25

96

Beatriz Gros

@Bealoquebea

30 days

People often ask me how I manage to tweet so quickly during congresses Here's the trick!!!: I prep every session beforehand. 🌟 I compile a Word doc with titles, dates/rooms, and abstracts, which I print and take along for note-taking. Why? 1⃣ Gain insight before the talk 2⃣

3

8

94

Beatriz Gros

@Bealoquebea

6 months

🔬 Our latest real-world cohort study unveils exciting insights into Filgotinib's impact on ulcerative colitis treatment. First real-world evidence published. #UlcerativeColitis #Filgotinib #UC 1/4

2

27

94

Beatriz Gros

@Bealoquebea

18 days

Perianal and intra abdominal fistulizing #CD management ✅team with the surgeons ❌antibiotics alone ✅antiTNF ❓other drugs Great overview by @MRegueiroMD at @DDWMeeting #DDW2024

1

30

93

Beatriz Gros

@Bealoquebea

2 years

3rd update of the timeline of IBD trials & studies. Thanks to all of you writing to remind me the missing ones. Team work 🤩 More than 120 studies. Doing this has been so helpful to organize my knowledge,hope this can help others.

8

23

90

Beatriz Gros

@Bealoquebea

2 months

This month in new additions! ⭐️ 12 new summaries in the timeline ⭐️ New cheat sheets and much more!! If you don't want to miss any of these you can subscribe for free If you don't enjoy it you can cancel anytime, we will miss you but this will allow

1

22

86

Beatriz Gros

@Bealoquebea

4 months

Do not miss our work about authorship gender representation of #IBD trials from 1955-2023 You will find it at #ECCO2024 poster presentation number 791 ⭐️this work has been possible thanks to @JosephHabibi_MD @BassiMehak @DCharabaty

4

21

88

Beatriz Gros

@Bealoquebea

1 year

Kono-S anastomosis associated to ⬇️ risk of postop recurrence in CD. Disease extension >50cm associated to ⬆️ recurrence. The SUPREME-CD trial presented by Gaetano Luglio at #DDW2023 #AGALIVE2023 @DDWMeeting @geteccu

2

31

87

Beatriz Gros

@Bealoquebea

1 year

Monitoring calprotectine in IBD using a sweat wearable device. Amazing future to come #DDW2023 #AgaLive2023 @geteccu @DDWMeeting

6

20

86

Beatriz Gros

@Bealoquebea

1 year

Outstanding opening talk about sequencing therapy in #CD at #ecco2023 by @IBDMD #IBD

4

20

82

Beatriz Gros

@Bealoquebea

18 days

TDM in #IBD , when it refers at least to antiTNF there should be little to no debate on this topic at this stage but for some reason still is 🧐 Great summary from Adam Cheifetz At @DDWMeeting #DDW2024

4

27

84

Beatriz Gros

@Bealoquebea

1 year

Such an outstanding talk by @charlie_lees as always. Fascinating to finally see the @predicct study data at #DDW2023 #AGALIVE2023 @DDWMeeting

8

18

81

Beatriz Gros

@Bealoquebea

6 months

Speechless seeing the impact of the latest post on the website! Over 23k visits in 4 days, now soaring past 180k in under 10 months. Grateful for the trust in my work—this support only fuels my drive to keep pushing boundaries. Thank you all!

Beatriz Gros

@Bealoquebea

6 months

🌟 November-Exciting News IBD-EII! 🌟 🧵 🆕 Introducing the new "IBD multifactorial" section at Delve into the risk & protective factors that have been associated with IBD onset. Over 190 studies organized per year and type of factor!

11

78

207

7

82

Beatriz Gros

@Bealoquebea

1 year

Ileocaecal resection may have a role as first-line therapy in #CD , findings supporting the results from the LIR!C trial 🤩 Congratulations @ManasiAgrawalMD @JeanFredericCo1 @ryanungaro @DrTineJess and rest of authors

1

21

81

Beatriz Gros

@Bealoquebea

1 year

IBD Family plus loads of missing people This is the biggest motivation to come to #ECCO2023 @DCharabaty @AshkanRA @DrMohamadShehab @AlfonsoElosua @PaulaCRFSousa @bverstockt @ign76 @LauranneDerikx @LumirKunovsky @JosephHabibi_MD #Petr #Nuru

6

9

80

Beatriz Gros

@Bealoquebea

15 days

“Bea why do you tweet everything at conferences?” ⭐️there are many reasons, like benefiting those who cannot attend BUT one is purely for my own benefit Using twitter as a diary!! It helps me easily find & review data, prepare talks… 📹Here a video of an example Hope it

3

4

87

Beatriz Gros

@Bealoquebea

4 months

Personalized therapy in #IBD Greatly Presented by @SeverineVermei1 at #ECCO2024 #ECCO24

0

15

79

Beatriz Gros

@Bealoquebea

2 years

Muchísimas gracias a @saludigestivo y a la @sepdigestiva por este premio. Me siento muy afortunada. Y más compartiendo este rato con @mjgarciadig también premiada🤩

9

12

78

Beatriz Gros

@Bealoquebea

11 months

Subscribed to ? 📩 Get ready for a captivating month! Check the 'back to basics' in CD From pioneering AZA and steroid trials to the first cA2 (infliximab) experience Uncover these timeless, golden treasures. Don't miss out! #IBD ⬇️👀new timeline slides

4

18

76

Beatriz Gros

@Bealoquebea

4 months

🤔Ever found yourself thinking, 'Should I prescribe this drug for my IBD patient that will also treat his/her other IMID? Are you aware of which drugs are approved for which indications? It certainly confuses me🫣 Just until now,

4

20

77

Beatriz Gros

@Bealoquebea

1 year

This #ecco2023 has been great to learn, to share experiences, to see colleagues and friends again. Cannot express enough how wonderful has been to meet again.

5

9

77

Beatriz Gros

@Bealoquebea

8 months

Some of the fantastic things of international congresses is getting to know outstanding people at @my_ueg I had the pleasure to meet @ebtapper worldwide known for his passion on hepatology education. The liver meets the gut 😊 #SoMe #MedEd #uegweek23 #UEGweek

1

2

72

Beatriz Gros

@Bealoquebea

1 year

Some of our Edinburgh IBD unit posters 🤩🤩 fantastic work team!!! @reb_hal @Gwotzerho @IBDNathan @charlie_lees @Gastro_GRJ @ShahidaDin1 @AKA_Dr_E_Watson @Edin_IBDScience @PlevrisN @LauranneDerikx @mathewlyons @claire_ohare_

2

11

72

Beatriz Gros

@Bealoquebea

1 year

Managing and understanding perianal fistulas in CD very nicely presented by @HolubarStefan at #DDW2023 #AGALIVE2023 @DDWMeeting

0

26

72

Beatriz Gros

@Bealoquebea

8 months

Upadacitinib efficacy and safety in #CD , final results from the phase 3 trial U-ENDURE Presented by Julian Panés at #UEGWeek

0

15

71

Beatriz Gros

@Bealoquebea

10 months

The role of the appendix in #IBD is intriguing. ⬆️ the risk of CD ⬇️ the risk of UC & clinical course may be milder ‼️This new study presents relevant data regarding possible relationship between appendicectomy & advanced colorectal neoplasia in #UC

Appendectomy and Risk of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: A Nationwide...

AbstractBackground. The aim of this study was to examine the association between appendectomy and advanced colorectal neoplasia (aCRN) in patients with inf

academic.oup.com

3

20

72

Beatriz Gros

@Bealoquebea

16 days

VIVID-1 h2h trial with mirikizumab vs ustekinumab in #CD ✅mirikizumab achieved non-inferiority to ustekinumab ❗️Be aware this is not like SEQUENCE! Patients here were around 50% previously exposed to AntiTNF whereas SEQUENCE all were previously exposed and the trial design

2

27

71

Beatriz Gros

@Bealoquebea

2 years

The importance of dietician help to manage patients with IBD not only during active disease but also to reduce functional associated symptoms when they are in remission presented by Lauren Manning #UEGWeek #UEGWeek22 @my_ueg

1

18

71

Beatriz Gros

@Bealoquebea

2 years

Mistakes in surveillance in IBD presented by @Rutter_Matt very clear and useful presentation #UEGWeek22 #UEGweek @my_ueg

1

25

70

Beatriz Gros

@Bealoquebea

4 months

Mi hermana es médico de rescate en el helicóptero que cubre el Pirineo Aragonés Es una de las personas mas increíbles que he conocido y valiente como nadie Este domingo sale en RTVE en un programa en el que muestran lo que hacen ella y su equipo 🤍

6

5

68

Beatriz Gros

@Bealoquebea

4 months

We lack data on proctitis in clinical trials, and information regarding whether left-sided colitis and extensive colitis respond differently is scarce. ⭐️This study provides valuable insights regarding tofacitinib response depending on disease extension

3

13

66

Beatriz Gros

@Bealoquebea

3 months

High definition white light endoscopy with segmental re-inspection 🔦 is non-inferior than dye-based chromoendoscopy in #IBD the HELIOS trial Great talk by Marteen te Groen ar #ECCO2024 #ECCO24

2

17

66

Beatriz Gros

@Bealoquebea

8 months

🌟Exciting news! This month, I've been dedicated to enhancing the "Evidence Corner" on , based on your feedback. I've refreshed the "type of drug" section with the latest insights. 1/4

6

15

65

Beatriz Gros

@Bealoquebea

1 year

Results from the TORUS study: TOFA vs UST in antiTNF exposed UC patients #DDW2023 #AGALIVE presented by Anthony Buisson #IBD

2

15

66

Beatriz Gros

@Bealoquebea

1 year

ECCO Topical Review on Biological Treatment Cycles in Crohn’s Disease Congratulations @PaulaCRFSousa @fgomollon @maria_chs @jp_gisbert @TrianaLobaton @PFvRheenen @MJCasanovaG @peter_bossuyt @BettenworthDb @GabrieleDragoni and rest of authors

ECCO Topical Review on Biological Treatment Cycles in Crohn’s Disease

Abstract. There are now a growing number of licensed biological therapies for patients with Crohn’s disease. However, there can be significant costs associ

academic.oup.com

2

21

65

Beatriz Gros

@Bealoquebea

2 years

Today is ostomy awareness day. I am going to share some interesting data that some of you may know. I hope this will help to raise awareness about this situation which is a life saver for many patients.

2

29

64

Beatriz Gros

@Bealoquebea

2 years

Outstanding lecture @JoanaTo62523004 going through the evidence to support the superiority of TNFinh in CD ✅perianal disease ✅EIMS ✅long term safety data (including pregnancy) ✅also cheap (Difficult to choose 4 slides as there were super) @my_ueg #UEGWeek #uegweek22 #IBD

3

21

64

Beatriz Gros

@Bealoquebea

2 years

I am writing a post about Ramadan fasting and IBD.I am astonished there is only 1 study in pubmed published in 2008 which analyzed this. The recommendations I found have sense but are expert opinions. Now it is Ramadan&we have many muslims patients,appropriate info is needed.

5

8

62

Beatriz Gros

@Bealoquebea

1 year

Today starts Ramadan Little reminder that we have little knowledge of the impact of this period on IBD course&recommendations are based on poor quality data 🤔taking into account it is 1 month/y & the amount of muslims in the🌍this is not admissible

Beatriz Gros, MD (@dr.beatrizgros) • Instagram photos and videos

www.instagram.com

5

12

62

Beatriz Gros

@Bealoquebea

1 year

We know Helicobacter Pylori is a group 1 carcinogen due to its link to gastric cancer. But what about other solid malignancies? What about other Helicobacter species? Our latest publication in Cancers tries to shed a little bit of light in this regards ⬇️⬇️⬇️

5

13

62

Beatriz Gros

@Bealoquebea

2 years

Flying back home, therefore I stop my retransmission of the #UEGWeek22 highlights. It’s been a pleasure to see so many of you interacting with me and valuing my tweets. See you at the ECCO 😊

6

2

62

Beatriz Gros

@Bealoquebea

3 months

Family planning, pregnancy and lactation Great review at #ECCO2024 #ECCO24 @JulsgaardMette and Irit Avni Biron

1

18

62

Beatriz Gros

@Bealoquebea

11 months

LUCENT-1 and LUCENT-2 trials published!! 🌟mirikizumab (anti IL23) 🔎induction 300mg IV vs placebo clinical remission w8 (24.2 vs 13.3, p<0.001) 🔎maintenance 200mg SC clinical remission w40 (49.9% vs 25.1%, p<0.001)

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis | NEJM

Mirikizumab, a p19-directed antibody against interleukin-23, showed efficacy in the treatment of ulcerative colitis in a phase 2 trial. We conducted two phase 3, randomized, double-blind, placebo-c...

www.nejm.org

3

18

61

Beatriz Gros

@Bealoquebea

11 months

Gaining perspective is not always easy but necessary In #IBD a major source are Cochrane reviews ⭐️A new section is available as “IBD library” with all the IBDCochrane reviews for now (60 in total) Some surprised me when I first read them🤩guess which

0

19

61

Beatriz Gros

@Bealoquebea

17 days

Life is so much richer when you're surrounded by people who inspire you to be better, do more, and reach for your dreams. I'm so lucky to have found a group of friends who not only support me but also challenge me to grow @DCharabaty @JosephHabibi_MD @LumirKunovsky #DDW2024

1

2

61

Beatriz Gros

@Bealoquebea

17 days

Oral small molecules not associated with cancer risk in #IBD patients ✅up to 4 years of drug use ✅no differences vs biologics ✅subgroup analysis of patients >50years old still no differences Presented by Thabet Qapaja @DDWMeeting #DDW2024

1

24

60

Beatriz Gros

@Bealoquebea

1 year

Today 9/4/23 it's just 2 months since the website was launched I wanted to share some reflections and more importantly to 🙏thank you all🙏 for your appreciation and kind words plus the help that some of you gave me by reminding me missing studies 🧵

4

5

60

Beatriz Gros

@Bealoquebea

4 months

Inverse association between legume intake & colorectal cancer risk Compared to no consumption: - OR for at least 1 portion of legumes 0.79 (0.68-0.91) -OR for 2 or > 0.68 (0.57-0.82) & estimate for an increment of 1 portion per week 0.87 (0.81-0.93)

2

18

60

Beatriz Gros

@Bealoquebea

6 months

This study is very nice to read! People expecting to eat gluten (even if they were not) had more symptoms than those not expecting gluten (even if they were really taking it)

The Lancet Gastroenterology & Hepatology

@LancetGastroHep

6 months

New research - de Graaf et al The effect of expectancy versus actual gluten intake on gastrointestinal and extra-intestinal symptoms in non-coeliac gluten sensitivity: a randomised, double-blind, placebo-controlled, multicentre study #GITwitter #Gluten

3

15

47

4

12

58

Beatriz Gros

@Bealoquebea

19 days

Great talk on how diet may lead to gut inflammation in #IBD Presented by Kenneth Croitoru at @DDWMeeting #DDW2024

0

14

58

Beatriz Gros

@Bealoquebea

1 year

🌟New ECCO guideline on Extraintestinal manifestations in #IBD Congratulations to all the authors for this big piece of work @manu_barreiro @GianlucaPellino @TrianaLobaton @PascalJuillerat and rest of colleagues

1

13

56

Beatriz Gros

@Bealoquebea

4 months

Wishing a phenomenal birthday to my extraordinary friend and mentor @charlie_lees ! 🎉 Your wisdom and kindness have been a beacon of inspiration, and I'm incredibly grateful for all I've learned from you. Here's to celebrating the amazing person you are! 🥳🎂 #BirthdayCheers

10

1

56

Beatriz Gros

@Bealoquebea

2 years

No-healthcare professionals are giving different advice to IBD patients in social media which confuses them.I decided to create an account in which I share information for patients/clinicians...Trying to bring science closer in a visual way⬇️written in🇬🇧🇪🇸

6

17

55

Beatriz Gros

@Bealoquebea

4 months

DDW this year 🤩 It brings me joy to get to see colleagues &friends from across the 🌍 3 posters: 1) with the incredible support of @JosephHabibi_MD @DCharabaty @BassiMehak 2) alongside the fantastic team from Edinburgh 3) My website Grateful for these opportunities! #DDW2024

2

3

56

Beatriz Gros

@Bealoquebea

1 year

For those subscribed to you may have received this month’s updates ⭐️This month: - New web section: IBD classifications - New summary in “evidence corner” - 22 new studies in the “timeline”

1

10

54

Beatriz Gros

@Bealoquebea

8 months

Fabulous talk through the evidence of diet in #IBD by @ProfWhelan at #UEGweek #UEGweek23 @my_ueg

1

15

55

Beatriz Gros

@Bealoquebea

1 year

Withdrawal of thiopurines in VDZ treated UC in clinical rem >6 months -No change in VDZ levels -BUT Lower FC remission and lower histo and histoendoscopic remission 🏥multi-centre not patient blinded controlled trial Aviv Pedipedi very nice talk #DDW2023 #IBD #AGALIVE2023

3

14

54

Beatriz Gros

@Bealoquebea

17 days

Fantastic study full of information regarding the impact of maternal food additive consumption on gut microbiome and vertical bacteria sharing between #IBD mothers and their infants Presented by Lin Zhang at @DDWMeeting #DDW2024

3

17

55

Beatriz Gros

@Bealoquebea

8 months

Checking the complexity of new agents and options that are/will soon be available in #IBD by @SeverineVermei1 at #UEGweek

3

9

55

Beatriz Gros

@Bealoquebea

17 days

QUASAR maintenance phase 3 trial of Guselkumab in mod-severe #UC Primary endpoint and all secondary outcomes were met Presented by @IBDMD at @DDWMeeting #DDW2024

0

12

54